Hydroperoxides in Plasma Are Reduced by Intensified Insulin Treatment: A randomized controlled study of IDDM patients with microalbuminuria

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Diabetes Care

• Publication date

  1998-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diacare.21.8.1295PMID 9702436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short-Term Insulin Therapy and Normoglycemia: Effects on erythrocyte lipid peroxidation in NIDDM patients

  1997cited by this paper
• Defective Plasma Antioxidant Defenses and Enhanced Susceptibility to Lipid Peroxidation in Uncomplicated IDDM

  1997cited by this paper
• Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

  1997cited by this paper
• Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus

  1997cited by this paper
• Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.

  1997cited by this paper
• Relationships between plasma measures of oxidative stress and metabolic control in NIDDM

  1997cited by this paper
• LDL From Patients With Well-Controlled IDDM Is Not More Susceptible to In Vitro Oxidation

  1996cited by this paper
• Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

  1996cited by this paper
• Effect of dietary fish oil supplementation on peroxidation of serum lipids in patients with non-insulin dependent diabetes mellitus.

  1996cited by this paper
• The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.

  1996cited by this paper
• The Absence of a Glycemic Threshold for the Development of Long-Term Complications: The Perspective of the Diabetes Control and Complications Trial

  1996cited by this paper
• Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans.

  1996cited by this paper
• Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations.

  1996cited by this paper
• Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM

  1995cited by this paper
• A fluorescence-based method for measuring total plasma antioxidant capability.

  1995cited by this paper
• Peroxidative Stress in Diabetic Blood Vessels: Reversal by Pancreatic Islet Transplantation

  1995cited by this paper
• Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus.

  1995cited by this paper
• Reduced Plasma Peroxyl Radical Trapping Capacity and Increased Susceptibility of LDL to Oxidation In Poorly Controlled IDDM

  1994cited by this paper
• Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy

  1994cited by this paper
• Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.

  1994cited by this paper
• Inactivation of Cu,Zn-Superoxide Dismutase by In Vitro Glycosylation and in Erythrocytes of Diabetic Patients

  1994cited by this paper
• High glucose can induce lipid peroxidation in the isolated rat glomeruli.

  1994cited by this paper
• Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction?

  1994cited by this paper
• Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives.

  1994cited by this paper
• Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine.

  1994cited by this paper
• Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

  1993cited by this paper
• Early glomerulopathy is present in young, Type 1 (insulin-dependent) diabetic patients with microalbuminuria

  1993cited by this paper
• Thrombogenic factors are related to urinary albumin excretion rate in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients

  1993cited by this paper
• Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test.

  1993cited by this paper
• Free radicals mediate endothelial cell dysfunction caused by elevated glucose.

  1992cited by this paper
• The Relationship of Oxidative Stress to Thrombotic Tendency in Type 1 Diabetic Patients with Retinopathy

  1991cited by this paper
• Role of Oxidative Stress in Development of Complications in Diabetes

  1991cited by this paper
• Autoxidative Glycosylation and Possible Involvement of Peroxides and Free Radicals in LDL Modification by Glucose

  1990cited by this paper
• Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing.

  1988cited by this paper
• Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes.

  1987cited by this paper
• Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of Type 2 (non-insulin-dependent) diabetic women

  1985cited by this paper
• [Enzymatic determination of total cholesterol in serum (author's transl)].

  1974cited by this paper
• Triglycerides Determination after Enzymatic Hydrolysis

  1974cited by this paper
• Enzymatic determination of total cholesterol in serum.

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used.

  1971cited by this paper

• Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC

  2022cites this paper
• Zinc, copper, and oxysterol levels in patients with type 1 and type 2 diabetes mellitus.

  2020cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

  2015cites this paper
• Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.

  2015cites this paper
• Oxidative Stress in Mongoloids and Caucasians with Type 1 Diabetes

  2014cites this paper
• Oxidative Stress in Patients with Type 1 Diabetes Mellitus: Is It Affected by a Single Bout of Prolonged Exercise?

  2014cites this paper
• Selective divalent copper chelation for the treatment of diabetes mellitus.

  2012cites this paper
• Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial

  2012cites this paper
• Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.

  2010cites this paper
• Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus

  2010cites this paper
• Glycation and Lipid Peroxidation in Children and Adolescents with Type 1 Diabetes Mellitus With and Without Diabetic Complications

  2009cites this paper
• Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

  2008influential citation
• Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance.

  2008cites this paper
• The role of oxidative stress in diabetic complications

  2007cites this paper
• Oxidative Stress in the Development of Diabetes and its Complications

  2006cites this paper
• Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus.

  2005cites this paper
• Oxidative Stress in Type 1 Diabetes: A Clinical Perspective

  2005cites this paper
• Relationship between lipid profile and lipid hydroperoxide levels in early stage type 1 diabetic patients

  2004cites this paper
• Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients.

  2004cites this paper
• Oxidative protein damage parameters in plasma in chronic experimental diabetes in rats.

  2003cites this paper
• Effects of alpha-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes.

  2002cites this paper
• Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference.

  2002cites this paper
• Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients.

  2002cites this paper
• Effects of α-tocopherol supplementation and continuous subcutaneous insulin infusion on oxidative stress in Korean patients with type 2 diabetes

  2002cites this paper
• Current Lipid-lowering Strategies for the Treatment of Diabetic Dyslipidemia: An Integrated Approach to Therapy

  2001cites this paper
• Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein

  2001cites this paper
• Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors

  2000cites this paper
• The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation‐mediated atherogenic modification of low density lipoprotein

  2000cites this paper
• Oxidative Protein Damage in Type I Diabetic Patients With and Without Complications

  2000cites this paper
• Glutathione in overweight patients with poorly controlled type 2 diabetes

  2000cites this paper
• COMPARISON OF OXIDATIVE STRESS INDICATORS IN PLASMA OF RECENT-ONSET AND LONG-TERM TYPE 1 DIABETIC PATIENTS

  2000cites this paper
• What is oxidative stress?

  2000cites this paper